A neurocognitive model for understanding treatment action in depression
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The way in which emotion is represented and processed in the human brain is an expanding area of research and has key implications for how we understand and potentially treat affective disorders such as depression. Characterizing the effects of pharmacological manipulations of key neurotransmitter systems can also help reveal the neurochemical underpinnings of emotional processing and how common antidepressant drugs may work in the treatment of depression and anxiety. This approach has revealed that depression is associated with both neural and behavioural biases towards negative over positive stimuli. Evidence from pharmacological challenge studies suggests that antidepressant treatment acts to normalize these biases early on in treatment, resulting in patients experiencing the world in a more positive way, improving their mood over time. This model is supported by evidence from both pharmacological and non-pharmacological interventions. The unique perspective on antidepressant treatment offered by this approach provides some insights into individual response to treatment, as well as novel approaches to drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Neural mechanisms of the cognitive model of depression.
Disner, S. G., Beevers, C. G., Haigh, E. A. P., & Beck, A. T. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3027 · Cited by 1,718
MacLeod, C., Rutherford, E., Campbell, L., Ebsworthy, G., & Holker, L. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.1.107 · Cited by 1,334
Sheline, Y. I., Barch, D. M., Donnelly, J. M., Ollinger, J. M., Snyder, A. Z., & Mintun, M. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01263-x · Cited by 1,191
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H., & Astrup, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61721-8 · Cited by 1,097
Hamilton, J. P., Etkin, A., Furman, D. J., Lemus, M. G., Johnson, R. F., & Gotlib, I. H. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11071105 · Cited by 866
Cognitive vulnerability to persistent depression
Teasdale, J. D. (1988) · Cognition & Emotion · doi:10.1080/02699938808410927 · Cited by 798
Murrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.022 · Cited by 786
Fu, C. H. Y., Williams, S. C. R., Cleare, A. J., Brammer, M. J., Walsh, N. D., Kim, J., Andrew, C. M., Pich, E. M., Williams, P. M., Reed, L. J., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.9.877 · Cited by 775
Research works printed but not linked: 44
- 10.1177/0269881110389092 · DOI · Paper page
- 10.1016/S0165-0327(98)00221-3 · DOI · Paper page
- 10.1016/j.tics.2006.10.013 · DOI · Paper page
- 10.1016/j.pnpbp.2004.05.036 · DOI
- 10.1097/00005053-199910000-00002 · DOI · Paper page
- 10.1177/0269881110376689 · DOI · Paper page
- 10.1038/npp.2014.159 · DOI · Paper page
- 10.1016/j.neuroimage.2007.05.036 · DOI
- 10.1017/S0033291713000731 · DOI · Paper page
- 10.1016/j.euroneuro.2010.06.008 · DOI
- 10.1016/j.euroneuro.2012.06.003 · DOI
- 10.1007/7854_2012_210 · DOI
- 10.1038/sj.mp.4002091 · DOI
- 10.1136/bmj.c4737 · DOI · Paper page
- 10.1017/S0033291714000221 · DOI
- 10.1007/BF02245224 · DOI
- 10.1177/0269881112474523 · DOI · Paper page
- 10.1016/0165-0327(89)90032-3 · DOI
- 10.1016/j.jad.2007.06.006 · DOI · Paper page
- 10.1016/0191-8869(94)00128-F · DOI
- 10.1038/mp.2011.16 · DOI
- Shaw K, 2002, Tryptophan and 5-hydroxytryptophan for depression, Cochrane Database Syst. Rev., 1, Cd003198
- Quera Salva MA, 2007, Major depressive disorder, sleep EEG and agomelatine: an open-label study, Int. J. Neuropsychopharmacol., 10, 691
- 10.1017/S0033291711002820 · DOI
- 10.4088/JCP.10m06176blu · DOI · Paper page
- 10.1007/s002130051177 · DOI
- 10.1007/s00213-002-1120-4 · DOI
- 10.1007/s00213-008-1082-2 · DOI · Paper page
- 10.1038/sj.npp.1300260 · DOI · Paper page
- 10.1017/S1461145709990150 · DOI · Paper page
- Godlewska BR, 2014, Early changes in neural response to emotional stimuli predict clinical response to SSRI treatment in depression, J. Psychopharmacol., 28, A45
- 10.1177/0004867414533837 · DOI
- 10.1038/nn1945 · DOI · Paper page
- 10.1523/JNEUROSCI.2124-13.2013 · DOI
- 10.3389/fimmu.2014.00475 · DOI
- 10.1016/j.biopsych.2007.01.011 · DOI
- 10.1038/sj.npp.1301439 · DOI
- 10.1007/s00213-009-1641-1 · DOI
- 10.1177/0269881114527361 · DOI · Paper page
- 10.1097/00001756-200303030-00018 · DOI · Paper page
- Deakin JFW Williams S Downey D McKie S Goodwin GM Rylands A Harmer CJ Craig KJ Dourish CT Dawson GR McCarthy CJ& Smith MA. 2012 PharmacoMRI and cognitive effects of the low-trapping NMDA channel blocker AZD6765 compared with ketamine in untreated major depressive disorder. 28th CINP World Congress of Neuropsychopharmacology Stockholm Sweden 3–7 June 2012. · doi:10.1016/s0924-977x(12)70397-8
- Stuart SA, 2012, Investigating the mechanism underlying delayed versus rapid antidepressant action using a novel rodent model of affective state-induced memory bias, J. Psychopharmacol., 26, A46
- 10.1111/j.1460-9568.2005.03968.x · DOI · Paper page
- 10.1186/1471-2202-10-48 · DOI · Paper page
Cited by
Impaired reward prediction error encoding and striatal-midbrain connectivity in depression
Kumar, P., Goer, F., Murray, L., Dillon, D. G., Beltzer, M. L., Cohen, A. L., Brooks, N. H., & Pizzagalli, D. A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0032-x · Cited by 219
Page, C. E., Epperson, C. N., Novick, A. M., Duffy, K. A., & Thompson, S. M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02625-2 · Cited by 80
“At the behavioral level, chronic SSRI administration improves the negativity bias in MDD and helps restore healthy emotional and cognitive information processing [74].”
Tamm, S., Harmer, C. J., Schiel, J., Holub, F., Rutter, M. K., Spiegelhalder, K., & Kyle, S. D. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21050466 · Cited by 22
Self-citationA single dose of fluoxetine reduces neural limbic responses to anger in depressed adolescents
Capitão, L. P., Chapman, R., Murphy, S. E., Harvey, C.-J., James, A., Cowen, P. J., & Harmer, C. J. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0332-2 · Cited by 22
Self-citationChanging the Way We Think About (and With) Antidepressants
Novick, A. M., & Ross, D. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.06.017 · Cited by 2
Metadata
- Authors
- Warren, M. B., Pringle, A., & Harmer, C. J.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2015-09-19
- Volume
- 370
- Issue
- 1677
- Pages
- 20140213
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2286702847
- Cited by
- 66
- References
- 66
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- royalsociety.org/journals/ethics-policies/data-sharing-mining/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A neurocognitive model for understanding treatment action in depression. https://app.cochat.ai/papers/10.1098/rstb.2014.0213
- The paper
- Warren, M. B., Pringle, A., & Harmer, C. J. (2015). A neurocognitive model for understanding treatment action in depression. Philosophical Transactions of the Royal Society B: Biological Sciences. https://doi.org/10.1098/rstb.2014.0213
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.